ABL503 (TJ-L14B), PD-L1X4-1BB BISPECIFIC ANTIBODY INDUCES SUPERIOR ANTI-TUMOR ACTIVITY BY PD-L1-DEPENDENT 4-1BB ACTIVATION WITH THE INCREASE OF 4-1BB+CD8+T CELLS IN TUMOR MICROENVIRONMENT

被引：0
|
作者：
Jung, Uijung [1 ]
Jeon, Jaehyoung [1 ]
Lee, Shinai [1 ]
Jin, Hyung-Seung [2 ]
Kim, Youngkwang [1 ]
Sung, Eunsil [1 ]
Kim, Hyunjoo [1 ]
Lim, Yangmi [1 ]
Won, Jonghwa [1 ]
Wang, Zhengyi [3 ]
Jiang, Wenqing [3 ]
Jung, Jaeho [1 ]
You, Gihoon [1 ]
机构：
[1] ABL Bio Inc, Seongnam, South Korea
[2] Asan Med Ctr, Seoul, South Korea
[3] I Mab Biopharma, Shanghai, Peoples R China
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.892
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
892
引用
收藏
页码：A935 / A935
页数：1
相关论文
共 50 条
  • [21] 4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+T Cells and Facilitates Tumor Abrogation
    Qu, Qiu-xia
    Zhu, Xin-yun
    Du, Wen-wen
    Wang, Hong-bin
    Shen, Yu
    Zhu, Yi-bei
    Chen, Cheng
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [22] GEN1046 (Bispecific Antibody Targeting PD-L1 and 4-1BB): Preclinical Characteristics and Phase 1 Results in Solid Tumors
    Kunkel, Maria
    Muik, Alexander
    Altintas, Isil
    Gieseke, Friederike
    Schodel, Kristina
    Diken, Mustafa
    Sette, Angelica
    Stanganello, Eliana
    Vascotto, Fulvia
    Breij, Esther
    Sasser, Kate
    Tureci, Ozlem
    Forssmann, Ulf
    Ahmadi, Tahamtan
    Sahin, Ugur
    CANCER SCIENCE, 2023, 114 : 1566 - 1566
  • [23] Fc-silenced bispecific antibodies targeting PD-L1 and 4-1BB combine checkpoint blockade and T-cell co-stimulation to promote anti-tumor activity
    Muik, Alexander
    Altintas, Isil
    Gieseke, Friederike
    Salcedo, Theodora
    Burm, Saskia
    Diken, Mustafa
    Grunwitz, Christian
    Schuurhuis, Danita
    Kreiter, Sebastian
    Satijn, David
    Tureci, Ozlem
    Breij, Esther
    Sahin, Ugur
    Jure-Kunkel, Maria
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [24] Targeting 4-1BB and PD-L1 induces potent and durable antitumor immunity in B-cell lymphoma
    Wang, Yichen
    Zhang, Xuyao
    Xu, Caili
    Nan, Yanyang
    Fan, Jiajun
    Zeng, Xian
    Kwon, Byoung S.
    Ju, Dianwen
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [25] Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity
    Rubio-Perez, Laura
    Frago, Susana
    Compte, Marta
    Navarro, Rocio
    Harwood, Seandean L.
    Lazaro-Gorines, Rodrigo
    Gomez-Rosel, Marina
    Hangiu, Oana
    Silva-Pilipich, Noelia
    Vanrell, Lucia
    Smerdou, Cristian
    Alvarez-Vallina, Luis
    ANTIBODIES, 2024, 13 (02)
  • [26] An Fc-muted bispecific antibody targeting PD-L1 and 4-1BB induces antitumor immune activity in colorectal cancer without systemic toxicity
    Cheng, Lian-sheng
    Zhu, Min
    Gao, Yan
    Liu, Wen-ting
    Yin, Wu
    Zhou, Pengfei
    Zhu, Zhongliang
    Niu, Liwen
    Zeng, Xiaoli
    Zhang, Dayan
    Fang, Qing
    Wang, Fengrong
    Zhao, Qun
    Zhang, Yan
    Shen, Guodong
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2023, 28 (01)
  • [27] An Fc-muted bispecific antibody targeting PD-L1 and 4-1BB induces antitumor immune activity in colorectal cancer without systemic toxicity
    Lian-sheng Cheng
    Min Zhu
    Yan Gao
    Wen-ting Liu
    Wu Yin
    Pengfei Zhou
    Zhongliang Zhu
    Liwen Niu
    Xiaoli Zeng
    Dayan Zhang
    Qing Fang
    Fengrong Wang
    Qun Zhao
    Yan Zhang
    Guodong Shen
    Cellular & Molecular Biology Letters, 28
  • [28] ATG-101, A TETRAVALENT PD-L1x4-1BB BSAB, DEMONSTRATES POTENT IN VIVO ANTI-TUMOR EFFICACY IN ICI-RESISTANT OR REFECTORY MOUSE TUMOR MODELS
    Hui Yuwen
    Li, Tengteng
    Ren, Yijing
    Mei, Jay
    Shan, Bo
    Hou, Bing
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1193 - A1193
  • [29] A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity
    Albu, Diana I.
    Wolf, Benjamin J.
    Qin, Yan
    Wang, Xianzhe
    Ulumben, Amy Daniel
    Su, Mei
    Li, Vivian
    Ding, Eirene
    Gonzalo, Jose Angel
    Kong, Jason
    Jadhav, Ruturaj
    Kuklin, Nelly
    Visintin, Alberto
    Gong, Bing
    Schuetz, Thomas J.
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [30] Activation of anti-tumor NK cells by gamma delta T lymphocytes through 4-1BB engagement
    Chapoval, Andrei
    Maniar, Amudhan
    Zhang, Xiaoyu
    Gastman, Brian R.
    Pauza, C. David
    Strome, Scott E.
    JOURNAL OF IMMUNOLOGY, 2009, 182
12345